Sandoz Announces Availability Of WYOST And Jubbonti In The US
2/6 07:36
(RTTNews) - Sandoz has announced that WYOST and Jubbonti are available to patients in the US. WYOST and Jubbonti are the first and only interchangeable FDA-approved denosumab biosimilars and are approved to treat all indications of the reference medicines XGEVA and Prolia, respe...